Journal Name: The Lancet Oncology
Journal Type: Q1
ISSN: 14702045, 14745488
Country: United Kingdom
Subject Area and Category: Medicine Oncology
Publisher: Elsevier Ltd
Research Ranking: 4
Publication Type: Journals
H-Index: 432
Coverage: 2000-2025
Editors-in-Chief: Allison Landman , Katherine Gourd
Research Impact Score: 79.6
Impact Factor: 54.433
SCIMAGO SJR: 11.319
APC Cost: $7,280
Submission Link: https://www.journals.elsevier.com/the-lancet-oncology
Contact Email: David.Collingridge@lancet.com
Address: Americas. Cambridge 50 & 60 Hampshire Street, 5th Floor Cambridge, MA 02139, USA.
Overview
The Lancet Oncology stands as one of the most respected and authoritative journals in the field of cancer research. A specialty journal under the prestigious Lancet family, it has established itself as a cornerstone of oncology literature, offering peer-reviewed, cutting-edge research that informs clinical practice and guides health policy worldwide.
What Is The Lancet Oncology?
Launched in 2000, The Lancet Oncology focuses exclusively on cancer-related topics, covering a broad spectrum from epidemiology and prevention to diagnosis, treatment, and survivorship. With a high impact factor and global readership, it is a go-to source for oncologists, researchers, and medical professionals seeking the latest breakthroughs and expert perspectives in oncology.
Key Features and Focus Areas
The journal publishes a variety of article types including original research, review articles, clinical trials, commentaries, and editorials. Key areas of interest include:
-
Cancer biology and genetics
-
Immunotherapy and targeted therapies
-
Global cancer burden and disparities
-
Clinical oncology and patient outcomes
-
Health policy and public health in cancer care
One of the distinguishing features of The Lancet Oncology is its commitment to publishing research that has real-world applications. Articles often emphasize clinical relevance, making it a valuable resource not just for academics but also for frontline clinicians.
Commitment to Global Oncology
The Lancet Oncology has a strong focus on global health, frequently publishing research on cancer care in low- and middle-income countries. Its dedication to reducing global disparities in cancer outcomes is evident through landmark series, such as the Lancet Oncology Commission reports. These often highlight pressing challenges like access to care, cost of cancer treatments, and regional health inequities.
Why The Lancet Oncology Matters
As cancer remains a leading cause of death globally, access to high-quality, evidence-based information is more critical than ever. The Lancet Oncology serves as a vital platform for the dissemination of impactful research that drives innovation, informs guidelines, and shapes public policy. For healthcare professionals, staying current with the journal means being at the forefront of oncology advancements.
Additionally, the journal plays a pivotal role in facilitating collaboration between institutions, countries, and disciplines, further accelerating progress in the fight against cancer.
About
The Lancet Oncology is one of the world’s leading peer-reviewed medical journals dedicated exclusively to cancer research, diagnosis, treatment, and prevention. Published by Elsevier as part of The Lancet family of journals, The Lancet Oncology has established itself as a trusted and authoritative voice in the global oncology community. Since its inception in 2000, the journal has consistently delivered cutting-edge research and expert commentary, making it a vital resource for oncologists, researchers, and healthcare professionals worldwide.
A Global Leader in Cancer Research
With a strong emphasis on innovation, clinical practice, and policy, The Lancet Oncology covers all aspects of oncology. The journal features high-impact original research articles, comprehensive reviews, insightful editorials, and timely clinical practice guidelines. Topics range from molecular biology and genetics to immunotherapy, radiotherapy, surgery, and palliative care.
The journal’s global reach and reputation ensure that it plays a key role in shaping the future of cancer care. It regularly publishes content from leading research institutions and contributes to international discussions on cancer burden, health equity, and access to care.
Peer-Reviewed Excellence
One of the defining characteristics of The Lancet Oncology is its rigorous peer-review process. All submissions undergo thorough evaluation by experts in the field, ensuring the highest standards of scientific accuracy, ethical conduct, and clinical relevance. This meticulous approach has helped The Lancet Oncology achieve a consistently high impact factor, making it one of the most cited journals in the field of oncology.
Innovative Features and Special Series
The Lancet Oncology frequently publishes special series, commissions, and reports on pressing issues in global cancer control. These include in-depth analyses on cancer in low- and middle-income countries (LMICs), the impact of environmental factors on cancer risk, and the role of artificial intelligence in cancer diagnosis and treatment.
The journal also offers multimedia features such as podcasts, infographics, and expert interviews, making complex research more accessible to a broader audience. Its digital presence and open-access options ensure that valuable insights are shared across borders, contributing to global knowledge and collaboration.
Trusted by the Oncology Community
For healthcare professionals, researchers, and policymakers, The Lancet Oncology serves as a reliable source of up-to-date information and expert guidance. Its influence extends beyond academia, with published findings often cited in policy documents, clinical guidelines, and global health strategies.
Scope
The Lancet Oncology is one of the world’s leading oncology journals, renowned for its rigorous peer-reviewed research and global impact on cancer treatment, prevention, and policy. As a specialty journal under The Lancet family, The Lancet Oncology serves as a critical platform for disseminating groundbreaking findings in the field of oncology. It plays a pivotal role in shaping cancer care practices and policies worldwide.
What Is The Lancet Oncology?
Launched in 2000, The Lancet Oncology focuses exclusively on cancer-related content. With a strong commitment to clinical excellence, the journal publishes high-quality research articles, reviews, editorials, commentaries, and perspectives on a broad spectrum of topics across oncology. The journal addresses issues ranging from early detection and diagnosis to innovative treatment modalities, survivorship, and palliative care.
Its global readership includes oncologists, researchers, policymakers, and healthcare professionals who rely on The Lancet Oncology for up-to-date, evidence-based insights into cancer care.
Key Areas of Focus
The scope of The Lancet Oncology is broad, encompassing:
-
Clinical Oncology: Clinical trials, treatment guidelines, and outcome studies in solid tumors and hematologic malignancies.
-
Translational Research: Bridging laboratory discoveries with clinical application, especially in targeted therapy and immuno-oncology.
-
Cancer Prevention and Epidemiology: Population-level research, screening strategies, and public health interventions.
-
Global Oncology: Studies and reports addressing disparities in cancer care, particularly in low- and middle-income countries (LMICs).
-
Health Policy and Ethics: Insightful discussions on access to cancer care, cost-effectiveness, and ethical considerations in oncology.
This wide-ranging scope ensures that the journal remains relevant across disciplines and geographic regions.
Impact on Global Cancer Research
The Lancet Oncology holds a high impact factor and is widely cited in academic and clinical literature. Its influence extends beyond academia, informing public health policy and clinical guidelines globally. The journal has been instrumental in elevating the visibility of underrepresented areas in oncology, including pediatric cancers, geriatric oncology, and cancer care in resource-limited settings.
It also plays a central role in advancing global health equity through initiatives such as The Lancet Oncology Commission, which brings together experts to tackle complex challenges in global cancer control.
Commitment to Innovation and Equity
In recent years, The Lancet Oncology has prioritized publishing content related to innovation in cancer diagnostics and treatment—such as precision medicine, AI in oncology, and CAR-T therapy. Additionally, the journal advocates for equitable access to cancer care, highlighting systemic inequalities and proposing actionable solutions.
By fostering dialogue between clinicians, researchers, and policymakers, The Lancet Oncology continues to be at the forefront of transformative change in the cancer research landscape.